Nanomolar cholera toxin inhibitors based on symmetrical pentavalent ganglioside GM1os-sym-corannulenes

Org Biomol Chem. 2013 Jul 14;11(26):4333-4339. doi: 10.1039/c3ob40438b. Epub 2013 Jun 4.

Abstract

Eight symmetric and pentavalent corannulene derivatives were functionalized with galactose and the ganglioside GM1-oligosaccharide (GM1os) via copper-catalyzed alkyne-azide cycloaddition (CuAAC) reactions. The compounds were evaluated for their ability to inhibit the binding of the pentavalent cholera toxin to its natural ligand, ganglioside GM1. In this assay, all ganglioside GM1os-sym-corannulenes proved to be highly potent nanomolar inhibitors of cholera toxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitoxins / chemistry*
  • Antitoxins / pharmacology
  • Cholera Toxin / antagonists & inhibitors*
  • Cholera Toxin / metabolism
  • G(M1) Ganglioside / analogs & derivatives*
  • G(M1) Ganglioside / metabolism
  • G(M1) Ganglioside / pharmacology
  • Galactose / chemistry*
  • Galactose / pharmacology
  • Polycyclic Aromatic Hydrocarbons / chemistry*
  • Polycyclic Aromatic Hydrocarbons / pharmacology

Substances

  • Antitoxins
  • Polycyclic Aromatic Hydrocarbons
  • corannulene
  • G(M1) Ganglioside
  • Cholera Toxin
  • Galactose